Chimeric Antigen Receptor T Cells Targeting Glypican-3

Clinical trial NCT03884751 · COMPLETED

Trial details

NCT number: NCT03884751
Sponsor: CARsgen Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-08-15
Primary completion: 2021-05-28
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.